Ozempic maker's new weight loss pill that is TWICE as good as blockbuster skinny jab won't be available in Britain and the US until 2026

Novo Nordisk yesterday unveiled promising early results for its experimental drug amycretin that showed patients could lose more than 13% of their weight after just 12 weeks.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news